ANTIDIABETIC EFFECT OF 50% HYDROETHANOLIC EXTRACT OF ARISTALOCHIA BRACTEOLATA LAM LEAVES IN STREPTOZOTOCIN- INDUCED DIABETIC RATS
K. Thangavelu* and V A Doss
Abstract
The present work was aimed to evaluate the antidiabetic effect of 50%
hydroethanolic extract of Aristalochia bracteolata Lam. leaves on 36
adult male albino Wistar rats weighing about 190-220 gms. Rats were
divided into 6 groups of 6 rats in each. Group-I served as normal
control while diabetes was induced in Group-II, III, IV, V and VI using
Streptozotocin at a dose of 55 mg/kg bw by intraperitonial injection.
After induction of diabetes Gtoup – II served as diabetic control. Group
– VI rats were treated with 600 μg/kg bw/day of standard drug
(Glibenclamide) while Group – III, IV and V rats were orally
administred with 50% hydroethanolic leaf extract of Aristalochia
bracteolata Lam. at the doses of 150, 300 and 450 mg/kg bw/day
respectively for 28 days. To determine hypoglycemic effect of 50%
hydroethanolic leaf extract of A. bracteolata Lam., blood and tissue
biochemical parameters were assayed in normal, diabetic control and treated groups. Oral
administration of 50% hydroethanolic extract of A. bracteolata Lam. leaves for 28 days
exhibited a significant (p
Keywords: Leaf extract of Aristalochia bracteolata Lam., Streptozotocin (STZ), Glibenclamide (GB) and antidiabetic effect.
[Full Text Article]